Lantern Pharma Inc. (LTRN): Price and Financial Metrics
LTRN Price/Volume Stats
| Current price | $3.43 | 52-week high | $6.12 |
| Prev. close | $3.34 | 52-week low | $2.55 |
| Day low | $3.28 | Volume | 55,000 |
| Day high | $3.48 | Avg. volume | 71,024 |
| 50-day MA | $3.45 | Dividend yield | N/A |
| 200-day MA | $3.72 | Market Cap | 36.99M |
LTRN Stock Price Chart Interactive Chart >
Lantern Pharma Inc. (LTRN) Company Bio
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-11, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
LTRN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
LTRN Price Returns
| 1-mo | -20.97% |
| 3-mo | -6.28% |
| 6-mo | -13.82% |
| 1-year | -40.96% |
| 3-year | -39.82% |
| 5-year | N/A |
| YTD | 7.52% |
| 2024 | -25.47% |
| 2023 | -29.14% |
| 2022 | -24.31% |
| 2021 | -58.55% |
| 2020 | N/A |